1. Home
  2. CYCC vs CRKN Comparison

CYCC vs CRKN Comparison

Compare CYCC & CRKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • CRKN
  • Stock Information
  • Founded
  • CYCC 1992
  • CRKN 2015
  • Country
  • CYCC United States
  • CRKN United States
  • Employees
  • CYCC 12
  • CRKN N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • CRKN Industrial Machinery/Components
  • Sector
  • CYCC Health Care
  • CRKN Technology
  • Exchange
  • CYCC Nasdaq
  • CRKN Nasdaq
  • Market Cap
  • CYCC 2.2M
  • CRKN 2.6M
  • IPO Year
  • CYCC N/A
  • CRKN N/A
  • Fundamental
  • Price
  • CYCC $0.36
  • CRKN $0.13
  • Analyst Decision
  • CYCC Strong Buy
  • CRKN
  • Analyst Count
  • CYCC 1
  • CRKN 0
  • Target Price
  • CYCC $11.00
  • CRKN N/A
  • AVG Volume (30 Days)
  • CYCC 6.4M
  • CRKN 110.5M
  • Earning Date
  • CYCC 11-12-2024
  • CRKN 11-14-2024
  • Dividend Yield
  • CYCC N/A
  • CRKN N/A
  • EPS Growth
  • CYCC N/A
  • CRKN N/A
  • EPS
  • CYCC N/A
  • CRKN N/A
  • Revenue
  • CYCC $74,000.00
  • CRKN $13,461,000.00
  • Revenue This Year
  • CYCC N/A
  • CRKN N/A
  • Revenue Next Year
  • CYCC $88.68
  • CRKN N/A
  • P/E Ratio
  • CYCC N/A
  • CRKN N/A
  • Revenue Growth
  • CYCC N/A
  • CRKN 22715.25
  • 52 Week Low
  • CYCC $0.31
  • CRKN $0.07
  • 52 Week High
  • CYCC $4.00
  • CRKN $90.00
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 43.22
  • CRKN 32.61
  • Support Level
  • CYCC $0.34
  • CRKN $0.07
  • Resistance Level
  • CYCC $0.39
  • CRKN $0.15
  • Average True Range (ATR)
  • CYCC 0.08
  • CRKN 0.03
  • MACD
  • CYCC 0.00
  • CRKN 0.02
  • Stochastic Oscillator
  • CYCC 6.30
  • CRKN 36.36

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.

About CRKN Crown Electrokinetics Corp.

Crown ElectroKinetics Corp is a provider of DynamicTint. The company's technology allows any glass surface to transition between clear and dark in seconds. DynamicTint allows windows to transition from transparent to black. With applications to a wide array of windows, including commercial buildings, automotive sunroofs, and residential skylights, Crown partners with glass and film manufacturers for mass production and distribution. Its technology is a thin film that is powered by an electrically-charged pigment which not only replaces common window tints but is also a more sustainable alternative to traditional window treatments. It is supported by a robust patent portfolio.

Share on Social Networks: